PL3243526T3
Delivery of rna to trigger multiple immune pathways
10 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10
53 members in 12 offices
Priority claims13
| Document | Office | Kind | Date |
|---|---|---|---|
| 36178910 | United States of America | P | |
| 36178910 | United States of America | P | |
| 11736499 | European Patent Office (EPO) | A | |
| 11736499 | European Patent Office (EPO) | A | |
| 17177123 | European Patent Office (EPO) | A | |
| 2011043104 | United States of America | W | |
| 2011043104 | United States of America | W | |
| 171771231 | – | – | – |
| 361789P | – | – | – |
| EP20110736499 | – | – | – |
| EP20170177123 | – | – | – |
| US20100361789P | – | – | – |
| WO2011US43104 | – | – | – |
Members53
| Document | Office | Kind | |
|---|---|---|---|
| WO2012006377A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2012006377A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP2590670A2 | European Patent Office (EPO) | A2 | |
| US2013177639A1 | United States of America | A1 | |
| EP2590670B1 | European Patent Office (EPO) | B1 | |
| US9801897B2 | United States of America | B2 | |
| EP3243526A1 | European Patent Office (EPO) | A1 | |
| ES2646669T3 | Spain | T3 | |
| US2018085388A1 | United States of America | A1 | |
| US2019343862A1 | United States of America | A1 | |
| EP3243526B1 | European Patent Office (EPO) | B1 | |
| US10532067B2 | United States of America | B2 | |
| LT3243526T | Lithuania | T | |
| DK3243526T3 | Denmark | T3 | |
| SI3243526T1 | Slovenia | T1 | |
| PT3243526T | Portugal | T | |
| HRP20200091T1 | Croatia | T1 | |
| PL3243526T3This record | Poland | T3 | |
| HUE047796T2 | Hungary | T2 | |
| ES2770335T3 | Spain | T3 | |
| US2020323896A1 | United States of America | A1 | |
| CY1122515T1 | Cyprus | T1 | |
| US2022054525A1 | United States of America | A1 | |
| US11291682B2 | United States of America | B2 | |
| US11324770B2 | United States of America | B2 | |
| US11596645B2 | United States of America | B2 | |
| US2023105639A1 | United States of America | A1 | |
| US2023110155A1 | United States of America | A1 | |
| US2023110963A1 | United States of America | A1 | |
| US2023111016A1 | United States of America | A1 | |
| US2023111638A1 | United States of America | A1 | |
| US2023112475A1 | United States of America | A1 | |
| US2023114029A1 | United States of America | A1 | |
| US2023114607A1 | United States of America | A1 | |
| US2023116636A1 | United States of America | A1 | |
| US2023117413A1 | United States of America | A1 | |
| US2023117454A1 | United States of America | A1 | |
| US2023181618A1 | United States of America | A1 | |
| US11690861B2 | United States of America | B2 | |
| US11690862B1 | United States of America | B1 | |
| US11690863B2 | United States of America | B2 | |
| US11690864B2 | United States of America | B2 | |
| US11690865B2 | United States of America | B2 | |
| US11696923B2 | United States of America | B2 | |
| US11707482B2 | United States of America | B2 | |
| US11717529B2 | United States of America | B2 | |
| US11730754B2 | United States of America | B2 | |
| US11759475B2 | United States of America | B2 | |
| US2023321132A1 | United States of America | A1 | |
| US11857562B2 | United States of America | B2 | |
| US11865080B2 | United States of America | B2 | |
| US12186333B2 | United States of America | B2 | |
| US2025302860A1 | United States of America | A1 |
Numbers
- Publication
- 3243526
- Publication, DOCDB
- 3243526
- Publication, EPODOC
- PL3243526T
- Application
- 17177123
- Application, DOCDB
- 17177123
- Application, EPODOC
- PL20170177123T
Titles2
- English
- DELIVERY OF RNA TO TRIGGER MULTIPLE IMMUNE PATHWAYS
- Polish
- DOSTARCZANIE RNA W CELU WYZWOLENIA WIELU SZLAKÓW IMMUNOLOGICZNYCH
Classification
- CPC, 8
- A61K31/7088
- A61K39/00
- A61K39/12
- A61K2039/53
- C12N2760/18522
- C12N2770/36143
- A61K2039/55555
- C12N2760/18534
- IPC, 2
- A61K39 00
- A61K39 12
